ImmunityBio Inc. (IBRX) Podcasts

1 episode across The Earnings Debate

ImmunityBio, Inc. Announced Full Year 2025 Earnings on March 3, 2026, Reporting "Full year net product revenue for ANKTIVA was $113 million" artwork

ImmunityBio, Inc. Announced Full Year 2025 Earnings on March 3, 2026, Reporting "Full year net product revenue for ANKTIVA was $113 million"

Mar 4, 2026 • 18:00 •Ep 51 •The Earnings Debate •▶ Play on Apple

biotechnologyimmunotherapyoncologypharmaceuticals